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Abstract
Cellular senescence involves epigenetic alteration, e.g. loss of H3K27me3 in Ink4a-Arf locus. Using mouse embryonic
fibroblast (MEF), we here analyzed transcription and epigenetic alteration during Ras-induced senescence on genome-wide
scale by chromatin immunoprecipitation (ChIP)-sequencing and microarray. Bmp2 was the most activated secreted factor
with H3K4me3 gain and H3K27me3 loss, whereas H3K4me3 loss and de novo formation of H3K27me3 occurred inversely in
repression of nine genes, including two BMP-SMAD inhibitors Smad6 and Noggin. DNA methylation alteration unlikely
occurred. Ras-activated cells senesced with nuclear accumulation of phosphorylated SMAD1/5/8. Senescence was bypassed
in Ras-activated cells when Bmp2/Smad1 signal was blocked by Bmp2 knockdown, Smad6 induction, or Noggin induction.
Senescence was induced when recombinant BMP2 protein was added to Bmp2-knocked-down Ras-activated cells.
Downstream Bmp2-Smad1 target genes were then analyzed genome-wide by ChIP-sequencing using anti-Smad1 antibody
in MEF that was exposed to BMP2. Smad1 target sites were enriched nearby transcription start sites of genes, which
significantly correlated to upregulation by BMP2 stimulation. While Smad6 was one of Smad1 target genes to be
upregulated by BMP2 exposure, Smad6 repression in Ras-activated cells with increased enrichment of Ezh2 and gain of
H3K27me3 suggested epigenetic disruption of negative feedback by Polycomb. Among Smad1 target genes that were
upregulated in Ras-activated cells without increased repressive mark, Parvb was found to contribute to growth inhibition as
Parvb knockdown lead to escape from senescence. It was revealed through genome-wide analyses in this study that Bmp2-
Smad1 signal and its regulation by harmonized epigenomic alteration play an important role in Ras-induced senescence.
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Introduction
Cellular senescence was first described as the limited replicative
capacity of primary cells in culture [1]. Activated oncogenes can
induce premature form of cellular senescence, and cells fall into
irreversible arrest to block cellular proliferation [2,3]. In addition
to cell death programs such as apoptosis and autophagy,
oncogene-induced senescence is recognized as a potent barrier
against oncogenic transformation, suppressing unscheduled pro-
liferation of early neoplastic cells [4–7].
Replicative senescence and oncogene-induced senescence are
known to comprise activation of tumor suppressor pathways
including p16
Ink4a-Rb and p19
Arf (p14
ARF in human)-p53
signaling cascades. Genetic and epigenetic inactivation of these
genes in cancer supported their crucial roles in senescence as
barriers to tumorigenesis [8,9]. Although the roles of RB and p53
signaling pathways in senescence are undisputed, it has become
clear that other factors are also involved. Expression of secreted
factors, or ‘‘senescence-messaging secretome’’, has been proposed
as an example of such mechanisms [10,11]. The induction of
senescence required several secreted factors including members of
Wnt, insulin, transforming growth factor-b, plasmin and interleu-
kin signaling cascades [11].
Epigenetic mechanism is also suggested to play important roles
in senescence. When human fibroblasts senesced, heterochromatic
regions condensed to form senescence-associated heterochromatic
foci, where regions with histone H3K9 trimethylation (H3K9me3)
gathered [12], and were recently shown to restrain DNA damage
response [13]. Expression of Jhdm1b, a demethylase specific for
H3K36me2, caused cell immortalization or leukemic transforma-
tion depending on its demethylase activity on p15
Ink4b, and its
knock down resulted in cellular senescence [14,15]. INK4A and
ARF region in young cells was repressed by H3K27me3 imposed
by the Polycomb Group proteins, and the repressive mark was lost
during oncogene-induced senescence, resulting in expression of
p16 and p19; the loss of repressive mark was also detected when
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senescence around seven passages [16–19]. Jmjd3, a histone
demethylase for H3K27, was found to be essential in senescence,
and its knock down lead to escape from senescence sustaining
repression of p16 by H3K27me3 [20,21].
In the previous studies, we comprehensively analyzed aberrant
promoter DNA methylation in colorectal cancer and reported
three distinct DNA methylation epigenotypes [22,23]. Distinct
methylation epigenotypes significantly correlated to different
oncogene mutation statuses, suggesting that epigenotypes of
cancer might perhaps be requisite phenotype of aberrant
methylation to escape from oncogene-induced senescence by
inactivation of critical factors of senescence [23,24]. To gain
insight in phenotype of critical gene inactivation in oncogene-
mutation(+) cancer, we aim to clarify critical genes/signals/
phenomena in oncogene-induced senescence in normal cells in this
study.
Here we perform genome-wide analyses of epigenetic and gene
expression changes in Ras-indeced senescence using mouse
embryonic fibroblasts (Figure S1). We show that Bmp2/Smad1
signal is critical in Ras-induced senescence, and is regulated by
coordinated epigenomic alteration. We further examine down-
stream target genes of this critical signal on genome-wide scale,
and show that the epigenomic regulation of the signal involves
disruption of negative feedback loop, and that activated down-
stream targets actually include a gene to contribute to growth
arrest.
Results
Gene expression analysis
To induce cellular senescence, mouse embryonic fibroblasts
after two passages (MEFp2) was infected with retrovirus of
oncogenic Ras (RasV12) with N-terminal FLAG tag and cultured
through day 10 (Figure S2A). RasV12-infected cells (RasV12 cells)
showed significant increase in number of SA-bgal(+) cells,
compared to MEFp2, MEF passed three more times without
infection (MEFp5), mock-infected cells (Mock cells), and wild type
Ras (RasG12)-infected cells (Figure 1A and Figure S2B).
Global gene expression analysis was performed using expression
array. In RasV12 cells on day 10, 822 genes were upreglated and
735 genes downregulated, by .5-fold compared to MEFp2
(Tables S1, S2). Gene annotation enrichment analysis suggested
that genes related to secreted protein (P=1.8610
219), extracellu-
lar region (P=1.2610
221), and differentiation/development
(P=3.8610
210), e.g. Bmp2 and Igfbp3, were upregulated, support-
ing the importance of secreted factor expression in senescence.
Genes related to cell cycle (P=7.2610
222) such as Cdc6 and Mcm5
were enriched in downregulated genes, indicating growth arrest.
Also genes related to secreted protein (P=7.9610
218) and
extracellular region (P=9.2610
214) such as Bmp4 and Tgfb2 were
enriched in downregulated genes, suggesting that dynamic control
of secretome by activation and repression of secreted factors
occurred during senescence.
Epigenomic alteration analysis
To analyze epigenomic gene regulation during Ras-induced
senescence, we selected H3K4me3 as an active mark and
H3K27me3 as a repressive mark, and mapped them by
Chromatin immunoprecipitation (ChIP)-sequencing. As reported,
H3K27me3 mark at p16
Ink4a-p19
Arf locus in MEFp2 was markedly
lost in RasV12 cells (Figure 1A). ChIP-sequencing of H3K4me3
showed concurrent gain of the active mark around p16
transcription start site (TSS), which reflected increase of p16
expression in RasV12 (Figure 1B). By quantitative ChIP-PCR,
significant gain of H3K4me3 and loss of H3K27me3 were
validated in RasV12 cells, compared to MEFp2 (Figure 1C). Gain
of H3K4me3 and loss of H3K27me3 were also detected at
intermediate level in Mock and RasG12 cells (Figure 1C).
Expression of p16 was also partially increased in Mock and
RasG12 cells, at the similar level to MEFp5 (Figure 1B). These
indicated that p16 expression could be induced partially by gain of
H3K4me3 and H3K27me3 during passages, which was in
agreement with the previous report of gradual H3K27me3 loss
in stress-induced senescence during 5–7 passages [16,18], but
more marked alteration occurred at this locus in Ras-induced
senescence. Enrichment of Ezh2, a member of the Polycomb
Group proteins, was also analyzed by ChIP-PCR, and it was
significantly decreased around p16 TSS in RasV12 cells compared
to MEFp2 (Figure 1D).
When analyzing distribution of 36-bp reads mapped around
TSS of 20,232 genes, the mapped reads were enriched within
62 kb of TSS, mainly 61 kb of TSS (Figure S3A), for both
H3K4me3 and H3K27me3. We counted mapped reads within a
window of genomic region, so that the number of mapped reads
per million reads within a window is regarded as epigenetic status
of the center position of the window. Within 62 kb from TSS of
each gene, the maximum number of mapped reads per million
reads in a window size of 300 bp (H3K4me3) or 500 bp
(H3K27me3) was regarded as the epigenetic status of each gene.
A wider window was necessary for H3K27me3 because distribu-
tion of H3K27me3 was rather wide than H3K4me3 (Figure 1A
and Figure S3A). The number of genes with repressive
H3K27me3 mark was generally decreased in RasV12 cells (Figure
S3B), in agreement of the previous reports [20,21] that expression
of Jmjd3 was increased during senescence, whereas expression of
Ezh2 was decreased (Figure S4). It was expected that genes
activated by losing H3K27me3 might exist other than p16 and
p19, because of the decrease of genes with H3K27me3 mark in
RasV12 cells.
Author Summary
To avoid becoming cancer cells, cells have a barrier system
to block cellular proliferation by falling into irreversible
growth arrest, so-called cellular senescence. For future
strategy of cancer treatment, it is important to understand
how cancer occurs, and investigation of the underlying
mechanism in senescence can lead to clarification of the
carcinogenesis mechanism. Epigenetic mechanism includ-
ing DNA methylation and histone modification may be
important to regulate gene expressions properly in
senescence. Here, taking advantage of recent technical
and methodological advance of genome-wide analyses,
we examine epigenome and gene expression alteration in
senescence induced by Ras oncogene. We identify that
Bmp2-Smad1 signal is critical. We further examine
downstream target genes of this critical signal on a
genome-wide scale. We show dynamic and coordinated
H3K27me3 alteration, e.g. activation of Bmp2 by loss of
H3K27me3, repression of the signal inhibitors and the
negative feedback loop by gain of H3K27me3, and
selective activation of downstream target genes that
may contribute to growth arrest. Our findings are helpful
in understanding the importance of epigenetic regulation
and a critical signal in the physiological barrier system
against oncogenic transformation and the importance of
disruption of BMP-SMAD signal in cancer, and they may
provide an idea how cancer with Ras mutation occurs.
Bmp2-Smad1 Signal in Senescence
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expression
Among 20,232 genes with epigenomic alteration analyzed,
16,793 genes were also analyzed for expression on array (Figure
S5). For epigenetic status of H3K4me3, 9,164 genes in MEFp2
and 8,841 genes in RasV12 showed .4 reads per million reads
around TSS, and regarded as H3K4me3(+). Similarly, 7,140 and
7,354 genes respectively with ,3 reads per million reads were
regarded as H3K4me3(-). Markedly higher expression levels of
H3K4me3(+) genes than H3K4me3(-) genes were confirmed by
comparing the mean of expression levels (Figure S5A). For
H3K27me3, 2,612 and 2,370 genes with .1.5 reads per million
reads around TSS were regarded as H3K27me3(+), and 13,205
and 12,841 genes with ,1 were as H3K27me3(-) in this study.
H3K27me3(+) genes were markedly repressed than H3K27me3(-)
genes (Figure S5B).
Among 284 genes losing H3K27me3 in RasV12 cells, 30 genes
losing H3K27me3 and gaining H3K4me3 simultaneously, like
p16, showed significant enrichment in upregulated genes among
the 284 genes (P=0.000007, Kolmogorov-Smirnov test,
Figure 2A). Among the 30 genes (listed in Table S3), Bmp2,a
secreted factor for BMP/SMAD pathway, was found to be the
most upregulated secreted factor and activated more than p16
(Figure 2A). Interestingly, 110 genes modified bivalently in MEFp2
showed loss of H3K27me3 and sustained H3K4me3 mark in
RasV12 cells, but did not show significant enrichment in
upregulated genes (P=0.9, Figure 2A).
Figure 1. Epigenomic alteration of Ink4a-Arf locus. (A) H3K4me3 and H3K27me3 mapped by ChIP-sequencing. Y-axis, number of mapped
reads per million reads, within window size of 300 bp for H3K4me3 and 500 bp for H3K27me3. 1, 2, 3; regions for ChIP-PCR. Right panels showed
SA-bgal(-) in MEFp2 and SA-bgal(+) in RasV12 cells. (B) Real-time RT-PCR for p16, normalized to Ppib. Fold expression levels compared to MEFp2
were shown. p16 expression was partially increased in MEFp5, Mock and RasG12 due to stress-induced senescence during passages, but markedly
increased in RasV12 cells. (C) Real-time ChIP-PCR for H3K4me3 and H3K27me3. In each sample of MEFp2, Mock cells, RasG12 cells and RasV12 cells,
relative enrichment compared to Actb was shown. Actb, a control region for H3K4me3. Gcgr and Dkk1, control regions for H3K27me3. Gain of
H3K4me3 and loss of H3K27me3 around p16 TSS were partially detected in Mock and RasG12 cells indicating partial epigenetic alteration during
passages, but markedly detected in RasV12 cells. (D) Real-time ChIP-PCR for Ezh2. Ezh2 enrichment was significantly decreased around p16 TSS
(*P,0.05, t-test).
doi:10.1371/journal.pgen.1002359.g001
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many as 239 genes showing H3K27me3 gain in RasV12 cells.
Nine genes gaining H3K27me3 and losing H3K4me3 simulta-
neously showed significant enrichment in downregulated genes
(P=0.0004, Figure 2B. Genes are listed in Table S4). Very
interestingly, two of the nine genes were Smad6 and Nog, inhibitors
for BMP-SMAD pathway [25]. The majority, 189 of the 239
genes, had neither modification in MEFp2 with very low
expression levels. These genes acquired de novo H3K27me3 mark
in RasV12 cells, but did not show any more downregulation
(P=1, Figure 2B).
Upregulation of Bmp2 in senescence
Around TSS of Bmp2, a secreted factor for BMP-SMAD
pathway, loss of H3K27me3and gain of H3K4me3 were validated
by quantitative ChIP-PCR (Figure 3A, 3B). ChIP-PCR also
showed that Ezh2 enrichment was significantly decreased around
Bmp2 in RasV12 cells (Figure S6).
ChIP-PCR showed that H3K4me3 and H3K27me3 levels in
MEFp2 were sustained in Mock and RasG12, but specifically
altered in RasV12 cells (Figure 3B). Quantitative RT-PCR showed
very low level of Bmp2 expression in MEFp2, Mock cells and
RasG12 cells, but marked increase to 91.6-fold in RasV12 cells
(Figure 3C). Bmp2 activation thus occurred specifically in Ras-
induced senescence, different from p16 that partially showed
increased expression and histone methylation alteration during
passages (Figure 1C).
Retrovirus to express shRNA against Bmp2 (shBmp2) was
infected together with RasV12 infection, to knock down Bmp2 to
0.04–0.08 fold on days 3, 7, and 10 (Figure 3D). Bmp2-knocked-
down RasV12 cells escaped from senescence with decreased
number of SA-bgal(+) cells compared to RasV12 cells. While
Smad1/5/8 is known to serve principally as substrates for BMP
receptors [26], western blotting analysis revealed phosphorylation
of Smad1/5/8 in RasV12 cells (Figure 3E). Decrease of Smad1/
5/8 phosphorylation level was also shown in Bmp2-knocked-down
RasV12 cells (Figure 3E), and continual cell growth faster than
Mock cells (Figure 3F). To confirm that this escape from
senescence was specifically due to Bmp2 knockdown, Bmp2-
knocked-down RasV12 cells were cultured with recombinant
Figure 2. Genes with H3K27me3 alteration. (A) 284 Genes losing H3K27me3 mark, i.e. from .1.5 in MEFp2 to ,1.0 in RasV12 cells (K27 column),
were sorted by the fold expression change between MEFp2 and mean of RasV12 cells day3, 7, and 10 (Expression column). Upregulated genes were
sorted upward (red). 30 genes losing H3K27me3 and gaining H3K4me3 simultaneously showed significant enrichment upward (Change K27RK4
column,
{P=0.000007, Kolmogorov-Smirnov test), e.g. p16. Bmp2 was found to be the most activated secreted factor among the 30 genes, and
activated more than p16. Genes are listed in Table S3. 110 genes with bivalent modification in MEFp2 lost H3K27me3 and sustained H3K4me3 mark in
RasV12 cells (BiRK4), but did not show significant enrichment upward (P=0.9). (B) 239 genes gaining H3K27me3 mark, i.e. from ,1.0 in MEFp2 to
,1.5 in RasV12 cells (K27 column). 189 genes had neither modification in MEFp2 (K27 column and K4 column), generally showed very low expression,
and did not show significant enrichment downward (P=1, (-)RK27). However, 9 genes gained H3K27me3 and lost H3K4me3 simultaneously, showed
significant enrichment downward (K4RK27, *P=0.0004), and included Smad6 and Nog. Genes were listed in Table S4.
doi:10.1371/journal.pgen.1002359.g002
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PLoS Genetics | www.plosgenetics.org 4 November 2011 | Volume 7 | Issue 11 | e1002359Figure 3. Bmp2 upregulation in senescence. (A) Maps around TSS of Bmp2 showing gain of H3K4me3 and loss of H3K27me3. 1, 2; regions for
ChIP-PCR. (B) Real-time ChIP-PCR showing H3K4me3 gain and H3K27me3 loss specifically in RasV12 cells. There was no alteration in Mock cells and
RasG12 cells, thus no alteration during passages. (C) Real-time RT-PCR analysis for Bmp2, showing upregulation to 92-fold specifically in RasV12 cells.
There was no increase in Mock cells and RasG12 cells, thus no alteration during passages. (D) Real-time RT-PCR showing knock-down of Bmp2 to 0.05–
Bmp2-Smad1 Signal in Senescence
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200 ng/mL in culture medium with 10% serum. The cells showed
increased number of SA-bgal(+) cells in dose-dependent manner,
even to the level of RasV12 cells when rBMP2 was at 200 ng/mL
(Figure 3G, 3H). The level of Smad1/5/8 phosphorylation was
increased when rBMP was added (Figure 3I), and growth curve
showed growth arrest similar to senescent RasV12 cells (Figure 3F).
These results indicated that Bmp2 upregulation plays an important
role in Ras-induced senescence. There was no increase of SA-
bgal(+) cells when Mock cells or MEF cells without infection were
exposed to rBMP2 at 200 ng/mL, indicating that increase of
BMP2 alone is not enough to induce cellular senescence
(Figure 3G).
Repression of Smad6 in senescence
As for Smad6, a specific inhibitor for BMP-SMAD pathway, gain
of H3K27me3 and loss of H3K4me3 in RasV12 cells were found
and validated by quantitative ChIP-PCR (Figure 4A, 4B).
H3K27me3 and H3K4me3 levels in MEFp2 were sustained in
Mock and RasG12 cells, and altered specifically in RasV12 cells.
This indicated that these alterations of histone methylation were
not detected in stress-induced senescence during passages, but
specifically occurred in Ras-induced senescence, like Bmp2.
Markedly decreased expression of Smad6 to 0.05-fold specifically
in RasV12 cells was also validated by quantitative RT-PCR, while
there was no repression of Smad6 during passages (Figure 4C).
Ezh2 enrichment was also analyzed by ChIP-PCR (Figure 4D).
This histone methyltransferase for H3K27 was significantly
increased around TSS of Smad6 in RasV12 cells. It was indicated
that Ezh2 was recruited to this de novo H3K27 trimethylation site,
and that repression mechanism by de novo H3K27me3 was still
active although Ezh2 expression level itself was downregulated
during senescence, and Jmjd3 expression level was upregulated
(Figure S4A).
Smad6 with N-terminal Myc tag was introduced to MEF by
retroviral infection together with RasV12 virus, and their
simultaneous expression was confirmed by cellular immunofluo-
rescence (Figure 4E and Figure S7). Western blotting analysis and
cellular immunofluorescence showed decrease of Smad1/5/8
phosphorylation in Smad6-introduced RasV12 cells compared to
RasV12 cells (Figure 4F, 4G). Smad6-introduced RasV12 cells
showed decreased number of SA-bgal(+) cells compared to
RasV12 cells (Figure 4H and Figure S8) and showed continual
cell growth faster than Mock cells or Smad6-introduced Mock cells
(Figure 4I). These data indicated that Smad6 repression was
important in Ras-induced senescence.
Repression of Nog in senescence
Nog, another inhibitor for BMP-SMAD pathway, was repressed
to 0.06-fold in RasV12 cells also by losing H3K4me3 and gaining
H3K27me3 (Figure 5A, 5B). Introduction of Nog cDNA by
retrovirus infection together with RasV12 resulted in its
overexpression and escape from senescence (Figure 5B–5D).
To clarify whether Nog at the physiological expression level
could inhibit cellular senescence, Nog-transgenic (Nog-Tg) mice
under Krt19 promoter [27] was used next, since the transgene was
expected not to be modified with de novo H3K27me3. Krt19 was
expressed in MEFp2 at much higher level compared to brain and
testis, confirming that Krt19 promoter is active in MEF (Figure S9).
Nog-Tg female mouse was crossed with C57B6, to establish and
pool Tg(-) and Tg(+) MEFs from embryos of the same mother.
Tg(+) MEF showed Nog expression at similar level to wild type
MEFp2 and Tg(-) MEF (Figure 5E). While Tg(-) MEF showed Nog
repression by RasV12 infection similarly to wild type MEF, Tg(+)
MEF did not show Nog repression by RasV12 infection and
showed continual growth faster than Tg(-) MEF (Figure 5E–5G).
These indicated that Nog repression was also important in Ras-
induced senescence.
No detection of DNA methylation alteration
It was reported that oncogenic Ras induces DNA methylation-
mediated epigenetic inactivation in NIH3T3 cells [28], and that
EZH2 directly controls DNA methylation [29,30]. We therefore
performed bisulfite sequencing to analyze DNA methylation
statuses of 59 regions of Smad6 and Bmp2 where increase or
decrease of Ezh2 was confirmed (Figure 4D, Figure S6). There was
no methylation alteration of these regions in RasV12 cells
compared to MEFp2 (Figure 6A). Also, Dnmt1 expression level
was not altered during Ras-induced senescence (Figure 6B). To
gain insight whether oncogenic Ras induces DNA methylation-
mediated inactivation in MEF on genome-wide scale, we
performed methylated DNA immunoprecipitation (MeDIP)-seq
in MEFp2 and RasV12 cells (Figure 6C, 6D). Although MeDIP is
reported to be not accurate to detect DNA methylation in low-
CpG regions, it is powerful screening method to detect candidate
methylation regions in high-CpG regions, e.g. promoter CpG
islands [22,23,31]. Increase of methylation was detected only in
three candidate genes, and the increase was considered as a noise
in genome-wide analysis because the increase was not validated by
bisulfite sequencing (Figure 6D, 6E). Bisulfite sequencing was
performed for five more genes which showed slight increase of
methylation in MeDIP-seq, but there was no methylation
alteration in RasV12 cells compared to MEFp2 (Figure 6F).
Ras-induced senescence of human fibroblast IMR90
Human fibroblast IMR90 was infected with RasV12 retrovirus
(RasV12-IMR90 cells). It was confirmed by SA-bgal staining on
day 7 that cells fell into premature senescence (Figure S10A). Real-
time RT-PCR showed that BMP2 expression was markedly
increased to 145-fold in RasV12-IMR90 cells, while SMAD6 and
NOG expressions were decreased to 0.32-fold and 0.15-fold,
respectively (Figure S10B). Nog was introduced in IMR90 by
0.08 fold by shRNA on days 3, 7, 10. Closed square, infected with RasV12 cells. Vertical-striped, infected with RasV12 and shBmp2. (E) Western blot
analysis showing increased level of Smad1/5/8 phosphorylation in RasV12 cells, and decrease in Bmp2-knocked-down RasV12 cells. RasV12 with N-
terminal FLAG was detected using anti-FLAG antibody. Numbers under bands of phosphorylated Smad1/5/8 and pan-Smad1 showed densities
relative to the band for RasV12 cells (left panel), and the ratio of densities for phosphorylated Smad1/5/8 to pan-Smad1 was decreased to 0.38-fold in
Bmp2-knocked-down RasV12 cells (right panel). (F) Growth curve. Bmp2-knocked-down RasV12 cells (red solid) showed continual growth faster than
Mock cells (black dotted). Growth of Bmp2-knocked-down Mock cells (co-infection of shBmp2 and Mock retroviruses, data not shown) was similar to
Mock cells. When cultured with rBMP2 (blue solid), the cells senesced like RasV12 cells (red dotted). (G) The number of SA-bgal(+) cells (%). When 0, 20,
and 200 ng/mL of rBMP2 protein (R&D systems #355-BM) were added to Bmp2-knocked-down RasV12 cells in culture medium with 10% serum, the
number of SA-bgal(+) cells was increased in dose-dependent manner. The number of SA-bgal(+) cells was not increased when Mock cells or MEF
without infection was exposed to 200 ng/mL of rBMP2 protein. (H) SA-bgal staining. Bmp2-knocked-down RasV12 cells showed decreased number of
SA-bgal(+) cells compared to RasV12 cells. When cultured with rBMP2 protein, the number of SA-bgal(+) cells was increased (representative result at
200 ng/mL rBMP2). (I) Western blot analysis showing increased level of Smad1/5/8 phosphorylation when exposed to 200 ng/mL of rBMP2.
doi:10.1371/journal.pgen.1002359.g003
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PLoS Genetics | www.plosgenetics.org 6 November 2011 | Volume 7 | Issue 11 | e1002359Figure 4. Smad6 repression in senescence. (A) Loss of H3K4me3 and gain of H3K27me3 around TSS of Smad6, shown by ChIP-sequencing. 1, 2, 3;
regions for ChIP-PCR. (B) Real-time ChIP-PCR showing H3K4me3 loss and H3K27me3 gain specifically in RasV12 cells. There was no alteration in Mock
cells and RasG12 cells, thus no alteration during passages. (C) Real-time RT-PCR analysis of Smad6, showing repression to 0.05-fold specifically in
RasV12 cells. There was no repression in Mock cells and RasG12 cells, thus no alteration during passages. (D) Real-time ChIP-PCR for Ezh2 showing
increased enrichment of Ezh2 around Smad6 TSS in RasV12 (*P,0.05). (E) Cellular immunofuorescence for RasV12 and Smad6. RasV12 with N-terminal
FLAG and Smad6 with N-terminal Myc were detected using anti-FLAG and anti-Myc antibodies. Simultaneous expression of RasV12 and Smad6
Bmp2-Smad1 Signal in Senescence
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IMR90 cells showed continual cellular growth (Figure S10C),
suggesting that BMP2-SMAD1 is also an effector program in
human fibroblasts.
Downstream target genes of Bmp2-Smad1 signal
analyzed by ChIP-sequencing
Since Bmp2 upregulation, Smad6 repression, and Nog repression
were shown to contribute to Ras-induced senescence, downstream
target genes of Bmp2-Smad1 signal are further analyzed on
genome-wide scale.
Smad1 binding sites in MEF were analyzed by exposing MEF to
rBMP and ChIP-sequencing usinganti-Smad1 antibody (Figure 7A
and Figure S11). Smad1 mostly bound to gene regions; 1,103
(75%) out of 1,479 Smad1 binding sites were located within 10 kb
from 20,232 RefSeq genes, and 818 sites (55%) were within 5 kb
from their TSS. Using GADEM (http://www.niehs.nih.gov/
research/resources/software/gadem/) [32], GGGGCGGGGC
was extracted as highly enriched motif within Smad1 binding
region in both whole genomic and TSS regions (Figure 6B, Figure
S12). Using DME (http://rulai.cshl.edu/dme/) [33], it was
confirmed that very similar motifs e.g. GGGCGGGGC
proteins in Smad6-introduced RasV12 cells was confirmed (See also Figure S7). (F) Western blot analysis showing increased level of Smad1/5/8
phosphorylation in RasV12, and decrease in Smad6-introduced RasV12 cells. Numbers under bands of phosphorylated Smad1/5/8 and pan-Smad1
showed densities relative to the band for RasV12 cells (left panel), and the ratio of densities for phosphorylated Smad1/5/8 to pan-Smad1 was
decreased to 0.25-fold in Smad6-introduced RasV12 cells (right panel). (G) Cellular immunofuorescence of phosphorylated Smad1/5/8. Nuclear
accumulation of phosphorylated Smad1/5/8 was detected in RasV12 cells, but not in Smad6-introduced RasV12 cells. (H) SA-b-gal staining. The
number of SA-b-gal(+) cells were significantly decreased in Smad6-introduced RasV12 cells compared with RasV12 (See also Figure S8). (I) Growth
curve. Smad6-introduced RasV12 cells showed continual growth faster than Mock cells or Smad6-introduced mock cells.
doi:10.1371/journal.pgen.1002359.g004
Figure 5. Nog repression in senescence. (A) Maps around TSS of Nog, showing increase of H3K4me3 and decrease of H3K27me3. (B) Real-time RT-
PCR analysis of Nog, showing repression to 0.06-fold in RasV12 cells, and overexpression to 159-fold in Nog-introduced RasV12 cells. (C) SA-bgal
staining. The number of SA-bgal(+) cells were decreased in Nog-introduced RasV12 cells compared with RasV12 cells. (D) Growth curve. Nog-
introduced RasV12 cells showed continual growth. (E) Real-time RT-PCR analysis. WT, wild-type C57/B6 MEF. Tg(-), Krt19-Nog transgene (-). Tg(+),
Krt19-Nog transgene (+). Nog was repressed to 0.09–0.15 fold by RasV12 infection in Tg(-) MEF, similar to wild type MEF. Nog expression in Tg(+) MEF
was detected at physiological level, and was not repressed by RasV12 infection. The increase of Nog expression from day 3 to day 10 might be due to
selection. (F) The number of SA-bgal(+) cells were less in Tg(+) MEF than Tg(-) MEF after RasV12 infection. (G) Tg(+) MEF showed faster growth
compared to Tg(-) MEF, after Rasv12 infection.
doi:10.1371/journal.pgen.1002359.g005
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TSS regarded as +1. Open circle, unmethylated CpG site. Closed circle, methylated CpG site. Nine to 10 clones were analyzed in each region, and
aligned vertically; 10 – 36 CpG sites within the analyzed regions were aligned horizontally. Since H3K27me3 mark in Smad6 was stretched towards
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This was in good agreement with the canonical SMAD1-bound
GC-rich elements [26,34,35] and the previous report that the
sequence GGCGGGGC was enriched within Smad1/5 binding
regions in ES cells and pulled down SMAD proteins [36]. Genes
with Smad1 binding site at TSS regions were significantly
enriched in active genes in MEF, especially in genes upregulated
by rBMP exposure (Figure 7C), suggesting that Smad1 binding
correlates to gene upregulation. Smad1 target genes upregulated
most by rBMP exposure included Smad6, which was upregulated
by 4.5-fold in MEF (Figure 7D, 7E). These indicated that Bmp2/
Smad1 signal in MEF could be controlled by negative feedback
through Smad1 regulation on Smad6.
Smad1 target genes repressed or activated during
senescence
However, Smad6 was repressed in RasV12 cells by H3K27me3,
so when Bmp2-knocked-down RasV12 cells was exposed to
rBMP2, Smad6 level was still suppressed lower than the level in
MEFp2 (Figure 7E). Smad1 target genes repressed in RasV12 cells
were not limited to Smad6. H3K27me3 gain during Ras-induced
senescence was detected in 50 Smad1 target genes, which were
enriched in genes repressed in RasV12 cells, e.g. Atoh8. Atoh8 was
highly upregulated in BMP2 exposure, but repressed in RasV12
cells with decrease of H3K4me3 from 8.7 to 1.8 and increase of
H3K27me3 mark from 1.0 to 1.8 (Figure 7C, Figure 8A and 8B.
Gene list is available in Table S5). It was reported that Atoh8 was,
like Id1, suggested to be a direct target of BMP-SMAD signal [37].
On the contrary, Smad1 target genes without increased
repressive mark were shown to keep upregulation. Among 838
Smad1 target genes, 581 with no increase of H3K27me3, or 156
showing decrease of H3K27me3, were significantly enriched in
genes upregulated in RasV12 cells (P=0.01 and P=0.004,
respectively, Figure 8A). If Bmp2/Smad1 signal is critical in
senescence, the most upregulated target genes are expected to
include genes with growth suppressor function. To choose such
candidate genes, the most upregulated target genes were screened
using promoter methylation data of our previous methylated
DNA-immunoprecipitation (MeDIP)-chip analyses of human
cancer cells [22,23] (Table S6), since such genes may possibly be
frequently inactivated in human cancer. The most upregulated
targets then included Parvb, which showed promoter methylation
in human cancer cell lines HCT116 and DLD1 (Table S6). When
MEF senesced, Parvb showed increase of H3K4me3 from 8.6 to
16.8, and decrease of H3K27me3 from 1.0 to 0.6 (Figure 8B).
Real-time RT-PCR validated increase of Parvb expression in
RasV12 cells, and also when exposed to rBMP2 (Figure 8C).
When Parvb was knocked down to 0.05-fold by shRNA, SA-bgal(+)
cells were partially decreased and cells showed continual growth
(Figure 8D and Figure S14). Western blot analysis showed
decrease of Akt phosphorylation in exposure to a growth factor
or serum when Parvb with C-terminal V5 tag was introduced in
MEF (Figure 8E).
Discussion
In this study, we examined H3K4me3 and H3K27me3 marks for
genome-wide analysis of epigenomic changes, revealing that
activation of Bmp2-Smad1 signal is important in Ras-induced
senescence and it is regulated by dynamic epigenomic alteration in
coordinated manner. Different from p16, H3K4me3 and
H3K27me3 marks on Bmp2 was not altered during passage in cell
culture, but specifically altered in RasV12 cells to induce its marked
upregulation, leading to Smad1/5/8 phosphorylation and cellular
senescence. Decrease of Ezh2and increase of Jmjd3 were detectedin
RasV12 cells at similar levels to MEFp5, Mock cells and RasG12
cells. This may contribute to partial increase of p16 expression in
MEFp5, Mock cells and RasG12 cells, and partial decrease of
H3M27me3 mark on p16 in stress-induced senescence during
passages as reported [16,18]. However, the alterations on p16 were
more markedly detected in RasV12 cells, and the alterations on
Bmp2 and Smad6 were specifically detected in Ras-induced
senescence and did not occur during passages. It is noteworthy
that de novo formation of H3K27me3 occurs on Smad6 in RasV12
cells in spite of general decrease of Ezh2 and increase of Jmjd3.
The mechanism how these epigenetic regulations are pro-
grammed is largely unknown, but one possible answer might be
non-coding RNA [38,39]. PRC2 was reported to be recruited in
trans to its target gene by virtue of its association with HOTAIR,a
2.2 kb non-coding RNA in the HOXC locus [40]. Oncogenic Ras
inhibited expression of ANRIL (antisense non-coding RNA in the
INK4 locus); ANRIL showed binding to CBX7 within PRC1 and
SUZ12 in PRC2, and was important in repressing the protein-
coding genes of INK4b/ARF/INK4a locus in cis to regulate
senescence [41,42]. Ezh2 recruitment was increased in Smad6,
and decreased in Bmp2 and p16 (Figure 1D, Figure 4D, Figure S6).
It would be interesting to analyze whether any non-coding RNAs
recruit PRC to Smad6 and Bmp2 in cis or trans, and their expression
alterations contribute to epigenetic alterations of these genes
during Ras-induced senescence.
Gene repressions by other epigenetic mechanism than Poly-
comb, such as H3K9 methylation, would be interesting to be
analyzed next. Human fibroblasts in senescence are reported to
suppress DNA damage response by forming heterochromatic foci,
where regions with methylated H3K9 gathered [12]. Amplifica-
tion of SETDB1, a methyltransferase for H3K9, was recently
reported to play an accelerating role in melanoma onset [13],
while knockout of Suv39h1, another histone methyltransferase for
H3K9, caused escape from senescence of lymphocytes [43],
suggesting necessity of adequate control of H3K9 methylation.
Genome-wide analyses of methylated H3K9 and other epige-
nomic marks as well would be helpful to obtain the whole picture
of epigenomic alteration and its importance in senescence.
exon 1 and intron 1 (Figure 3A), two regions (a and b) were analyzed for Smad6. There was no DNA methylation alteration in Smad6 and Bmp2. (B)
Real-time PCR for Dnmt1. Dnmt1 expression level was not altered in Ras-induced senescence, or during passages. (C) Validation of enrichment of
methylated DNA in MeDIP. MeDIP-PCR was performed for 59 regions of Nnat and p16 (region 1 in Figure 1A), and fold enrichment relative to p16 was
shown. Nnat is an imprinted gene and a positive control for DNA methylation(+) region, and enrichment of methylated DNA in MeDIP was validated.
(D) Analysis of MeDIP-seq. When analyzing 61 kb of TSS of 20,232 genes, only 3 genes showed increase of MeDIP status from ,2 reads per million
reads in MEFp2 to .4 reads per million reads in RasV12 cells. (E) Validation of MeDIP-seq result. Among the three candidate methylated genes, Adcy4
and Sdpr were chosen for validation by bisulfite sequencing. The methylation statuses of these genes, however, were not altered in Ras-induced
senescence. (F) Bisulfite sequencing for 59 regions of other genes. Among genes showing slight increase of MeDIP status, bisulfite sequencing was
performed for five chosen genes: Sfrp1 (from 0.7 reads in MEFp2 to 1.6 reads in RasV12 cells), Glt25d2 (from 0.9 to 2.5), Itga11 (0.6 to 2.7), Shisa2 (0.6 to
2.0), and Gypc (0.8 to 1.9). Sfrp1, Glt25d2, and Itga11 were representatively shown. These five genes were unmethylated in both MEFp2 and RasV12
cells.
doi:10.1371/journal.pgen.1002359.g006
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induces DNA methylation-mediated epigenetic inactivation in
NIH3T3 cells and that 28 responsible genes including DNMT1
are required for the methylation [28]. DNA methylation statuses
at 59 regions of Smad6 and Bmp2 were not altered, however,
indicating that expression changes of these genes during
senescence were not due to DNA methylation. Dnmt1 level was
not altered in RasV12 cells, either. Increase of methylation was
detected only in three candidate genes by MeDIP-seq analysis, and
the increase was considered as a noise in genome-wide analysis
because the increase was not validated by bisulfite sequencing.
Five more genes were chosen for bisulfite sequencing, because
Sfrp1 was reported to be methylated by oncogenic Ras in
NIH3T3[28], and four other genes were chosen randomly from
genes with slight increase of methylation in MeDIP-seq. There was
no methylation alteration in RasV12 cells compared to MEFp2,
either. Although MeDIP is not accurate to detect DNA
methylation in low-CpG regions [22,31], it was suggested that
DNA methylation unlikely occurs in Ras-induced senescence, at
least high-CpG regions e.g. promoter CpG islands. The
discrepancy between the previous report of NIH3T3 and our
MEF result may be because MEF falls into cellular arrest by
oncogenic stress and there might be no time enough to induce
DNA methylation alteration. In NIH3T3, cells transform by
Figure 7. Smad1 targets in MEF, analyzed by ChIP-sequencing. (A) Among 1,479 Smad1 binding sites identified, 1,103 sites (75%, blue and
orange) were located within 10 kb from 20,232 RefSeq genes, and 818 sites (55%, blue) were within 5 kb from their TSS. (B) GGGGCGGGGC was
obtained as an enriched motif by GADEM [32], in Smad1 binding region within both whole genomic (All, ln(E-value)=2279.2) and TSS regions (TSS,
ln(E-value)=2115.8). Very similar motifs were obtained by DME [33]. (See also Figures S9 and S10) (C) Correlation of Smad1 binding to gene
upregulation. Left, expression levels in MEF at 0–24 hours after rBMP2 exposure. Genes were sorted by fold-expression level between 0 h and the
mean of 3 h and 6 h. Right, 838 genes possessing Smad1 binding site in TSS region (black bars). Upper panel, genes with maximum GeneChip score
during 24 h .25 (i.e. active genes). Lower panel, genes with maximum GeneChip score ,25. Smad1 binding was significantly enriched in the upper
panel of active genes (
{P=2 610
257, Fisher’s exact test), especially upward within the upper panel (thus genes upregulated by rBMP exposure,
*P=2610
211, Kolmogorov-Smirnov test). Most upregulted genes included Atoh8, Smad6, Parvb (red, Smad1 target), and Nog (black, non-Smad1-
target). (D) Smad1 binding site around Smad6 TSS. (E) Real-time RT-PCR showing Smad6 upregulation in MEF by rBMP2 exposure. In Bmp2-knocked-
down RasV12 cells, Smad6 was suppressed lower than the level in MEFp2 even when exposed to rBMP2.
doi:10.1371/journal.pgen.1002359.g007
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PLoS Genetics | www.plosgenetics.org 11 November 2011 | Volume 7 | Issue 11 | e1002359Figure 8. Smad1 target genes repressed and activated in senescence. (A) Repression of Smad1 target genes by H3K27me3. 838 Smad1
target genes in MEF were sorted by fold expression change between MEFp2 and mean of RasV12 day3, 7, and 10 (Expression column). 50 genes
showed increase of H3K27me3 reads in RasV12 by 0.4 or more (qcolumn), and were significantly enriched downward (*P=0.004, Kolmogorov-
Smirnov test), i.e. repressed. Genes were listed in Table S5. 581 genes with no increase of H3K27me3 reads (not shown), or 156 genes showing
decrease of H3K27me3 reads by 0.4 or more (Qcolumn), were significantly enriched upward (P=0.01, and
{P=0.004, respectively), i.e. upregulated.
The former included Atoh8 and Smad6, and the latter included Parvb.( B) Maps around TSS of Parvb and Atoh8.( C) Real-time RT-PCR of Parvb. Parvb
expression was increased in RasV12 cells, or in exposure to rBMP2 in MEF. Compared to the level in RasV12 cells, Parvb expression level was
approximately half (0.5160.07 fold) when Bmp2 was knocked down (Ras+shBmp2), and increased to the similar level (0.9460.06 fold) when exposed
to rBMP. (D) Growth curve. Parvb-knocked-down RasV12 cells showed continual growth. (E) Western blot analysis of Akt phosphorylation. Parvb with
C-terminal V5 was detected using anti-V5 antibody. MEF’s with Parvb cDNA introduction and mock infection were stimulated by 50 ng/mL Igf1 or
10% fetal bovine serum (FBS). Akt was phosphorylated by Igf1 or serum stimulation in Mock cells, which showed very low Parvb expression (See also
Figure S14A). Akt phosphorylation by Igf1 or serum stimulation was decreased in Parvb-introduced cells.
doi:10.1371/journal.pgen.1002359.g008
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methylation during continuing proliferation. Or, two independent
cells, NIH3T3 (ATCC #CRL-1658) and K-ras-transformed
NIH3T3 (ATCC #CRL-6361), were compared in the previous
NIH3T3 study [28], so the result might be different if one
NIH3T3 clone is analyzed at time courses before and after
induction of activated Ras.
As for BMP-SMAD signals, utilization of four BMP type 1
receptors depends on BMP ligands; BMP2 and BMP4 utilize
BMPR1A and BMPR1B, BMP6 and BMP7 bind principally to
ACVR1, and BMP9 is a ligand for ACVRL1 and ACVR1 [26].
We reported that Smad6 inhibited BMPR1A/BMPR1B prefer-
entially to ACVR1/ACVRL1, and inhibited BMP2-induced
Smad1/5 phosphorylation more prominently than BMP6-induced
Smad1/5 phosphorylation [44]. This is in agreement with the
current results that Smad6 could cause decreased phosphorylation
of Smad1/5 and escape from senescence, and that coordination of
Bmp2 upregulation and Smad6 repression was critical in Ras-
induced senescence.
Our genome-wide analysis showed that Smad6 was a Smad1
target gene that could be highly upregulated by exposure to
BMP2, but strongly repressed in RasV12 cells with de novo
H3K27me3 mark. Previous reports showed that BMP-activated
Smad1/5 activates Smad6 expression through interaction with the
Smad6 promoter [45,46]. These suggested that Smad6 repression
with de novo H3K27 methylation blocks negative feedback loop to
sustain the effect of upregulated Bmp2, i.e. activation of Bmp2-
Smad1 signal in Ras-induced senescence. In other words, dynamic
H3K27me3 alteration is suggested to repress selectively the genes
which could negatively control senescent signal, and to activate
selectively genes which could positively affect senescent signal
(Figure 9). In fact, another BMP-SMAD inhibitor, Nog, was also
repressed by increased H3K27me3 mark. While ChIP-seq analysis
did not show Smad1 binding site around Nog TSS, Nog was also
highly upregulated by rBMP2 exposure (Figure 6C) and repressed
by increased H3K27me3 mark in RasV12 cells (Figure 5A, 5B).
This might suggest that Nog repression could also be a disruption of
negative feedback loop, though Nog is not a direct downstream
target of Bmp2-Smad1.
Parvb, which possessed Smad1 binding site around its TSS, was
upregulated in exposure to BMP2 or in RasV12 cells, and its
knock down lead to escape from senescence. While PARVA was
reported to bind to integrin-linked kinase (ILK) and play a
critical role in cell survival by promoting membrane recruitment
of Akt and its activation by phosphorylation, PARVB was
reported to compete PARVA in binding to ILK and reverse its
oncogenic effect by repressing ILK kinase activity [47,48]. As
PARVB introduction was reported to suppress cellular growth of
breast cancer cells with decreased Akt phosphorylation [49,50],
Parvb introduction in MEF also decreased phosphorylation of Akt
in exposure to a growth factor or serum (Figure 7E). It was
suggested that Parvb might be one of Bmp2-Smad1 target genes
playing a positive role in growth inhibition, at least partly, and
selectively and effectively activated through simultaneous
inactivation of negative regulators. We chose Parvb on the
assumption that candidate genes downstream of BMP-SMAD
might be inactivated by DNA methylation in full-blown cancers,
but other downstream genes that were not methylation target in
analyzed cancer cell lines might also play a positive role in
senescence.
Figure 9. Schema of epigenetic regulation of Bmp2/Smad1 signal. Negative factors for senescence were inactivated selectively and
epigenetically, and positive factors/signals for senescence were activated selectively and epigenetically.
doi:10.1371/journal.pgen.1002359.g009
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reported in human cancer. Juvenile polyposis syndrome, an
inherited syndrome with high risk of colorectal cancer, is caused
by germline mutation of BMPR1A or SMAD4 [51], and
importance of BMP signal is supported by its mouse model with
transgenic Nog expression or with Bmpr1a inactivation [52,53].
BMP2 expression was lost in microadenoma of familial adeno-
matous polyposis, while BMP2 was expressed in mature colonic
epithelial cells, promoting apoptosis and differentiation and
inhibiting proliferation [54]. Inactivation of BMPR1A, BMPR2,
and SMAD4 was frequently observed in sporadic colorectal
cancer, correlating to loss of Smad1/5/8 phosphorylation [55].
Colon epithelial polyps were developed even by alteration of BMP
pathway in the stromal microenvironment, using mice with
conditional inactivation of Bmpr2 in the stroma [56]. About
prognosis, Smad6 expression was reported to be elevated in 40%
of non-small cell lung cancer, and correlated to poorer outcome
[57]. BMP2 upregulation was reported in senescence of other cell
types, such as vascular smooth muscle cells [58]. Considering
frequent RAS gene mutation in cancer, e.g. colon (,40%) and
non-small cell lung cancers (,30%) [59], further experiments are
to be performed to clarify which cell types Bmp2-Smad1 signal is
critical in oncogene-induced senescence, and whether Bmp2-
Smad1 signal and its target genes are disrupted in cancer with
association to oncogene mutation.
Materials and Methods
Full information of Material and Methods is also described in
Supporting Materials and Methods (Text S1).
Cells and viral infection
MEF was established from 13.5 embryonic day embryos of
C57/B6 as reported [60]. After cells were passed twice (MEFp2),
cells were infected with retroviruses for 48 hours. Then cells were
exposed to 4 mg/mL puromycin for selection during days 0–3, and
were passed on days 3, 7, and 10. Human fibroblast IMR90
(JCRB9054) was purchased from Health Science Research
Resources Bank (Osaka, Japan), and 2 mg/mL puromycin were
used for selection after retrovirus infection. Total RNA was
collected using TRIzol (Invitrogen, Carlsbad, CA). This study was
certified by Animal Ethics Committee in Tokyo University.
MEF of Nog-trangenic (Nog-Tg) mice
Nog-Tg mice using keratin 19 gene promoter and mouse Nog
cDNA were previously established [27], and were crossed with
wild type C57/B6 mice five times to obtain C57/B6 background.
Nog-Tg female mouse was crossed with C57B6, and Tg(-) and
Tg(+) MEFs were established from 13.5 embryonic day embryos of
the same mother. Each embryo was minced separately, and Tg(-)
and Tg(+) MEFs were pooled after genotyping each MEF, and
used for experiments.
Retroviral vectors
Retroviral vectors for Ras was constructed by cloning cDNAs
for wild type HRAS (RasG12) and mutated HRAS (RasV12) by
reverse-transcription PCR products from HMEC and SK-BR3
cell RNA, respectively, with N-terminal FLAG tag into pMX
vector that contains puromycin resistance gene (a kind gift from T.
Kitamura). Mock pMX vector (Mock), and vectors containing
RasG12 and oncogenic RasV12 were transfected into plat-E
packaging cells (a kind gift from T. Kitamura) using FuGENE 6
Transfection Reagent (Roche, Germany) to prepare retroviruses.
Smad6 cDNA with N-terminal 6x Myc tag, Nog cDNA with C-
terminal V5 tag, and Parvb cDNA with C-terminal V5 tag were
also cloned into pMX vector. To knock down Bmp2 or Parvb,
double strand oligonucleotide DNA to express small hairpin RNA
against Bmp2 (shBmp2) or Parvb (shParvb), respectively, was cloned
into RNAi-Ready pSIREN-RetroQ Vector (Clontech, CA). Viral
packaging for Smad6, Nog, shBmp2 and shParvb retrovirus
vectors was also done using plat-E cells. Retroviruses of RasV12
and Nog for human fibroblast were prepared using Retrovirus
Packaging Kit Ampho (#6161, TaKaRa Bio Inc, Shiga, Japan).
Expression array analysis
For genome-wide transcription analysis, GeneChip Mouse
Genome 430 2.0 Array (Affymetrix) was used as described [61].
The GeneChip data were analyzed using the Affymetrix
GeneChip Operating Software v1.3 by MAS5 algorithms, to
obtain signal value (GeneChip score) for each probe. For global
normalization, the average signal in an array was made equal to
100. Gene annotation enrichment analysis was done at DAVID
Bioinformatics Resources (http://david.abcc.ncifcrf.gov/). Array
data is available at GEO datasets (#GSE18125).
ChIP, MeDIP, and sequencing
MEFp2 and infected cells at day 10 were cross-linked with 1%
formaldehyde for 10 min and were prepared for ChIP. ChIP using
anti-H3K4me3 (ab8580, abcam, rabbit polyclonal), H3K27me3
(07–142, Upstate, rabbit polyclonal), or Ezh2 (#39103, Active
Motif, rabbit polyclonal) antibody was performed as described
previously [62]. For ChIP using anti-Smad1 antibody (BioMatrix,
mouse monoclonal), MEFp2 cells were starved for 16 hours and
exposed to rBMP2 protein (#355-BM, R&D systems) at 25 ng/
mL in serum-free medium for 1.5 hours. Cells were cross-linked
with 1 mM Disuccinimidyl Glutarate (Thermo Scientific, Rock-
ford, IL) for 20 min and 1% formalin for 10 min, and ChIP was
performed similarly.
For MeDIP, genomic DNA of MEFp2 and RasV12 cells was
fragmented by sonication, and immunoprecipitated by anti 5-
methylcytocine monoclonal antibody (kindly supplied by Dr. K.
Watanabe, Toray Research Center, Inc.), as we previously
reported[22,23,63]. MeDIPed sample and Input sample under-
went MeDIP-PCR to check enrichment of methylated regions in
MeDIPed sample.
Sample preparation for ChIP- and MeDIP-sequencing was
performed according to the manufacturer’s instructions (Illumina),
and sequencing was performed using Solexa Genome Analyzer II
[61]. 36-bp single end reads were mapped to the NCBI Build #36
(UCSC mm8) reference mouse genome, using the Illumina
pipeline software v1.4. The numbers of uniquely mapped reads
for MEFp2 were 10,845,082 (H3K4me3), 11,519,151
(H3K27me3), 9,663,324 (DNA methylation) and 5,688,804
(Input), those for RasV12 cells were 13,246,871 (H3K4me3),
9,894,241 (H3K27me3), 11,319,506 (DNA methylation) and
6,126,206 (Input), and that for Smad1 ChIP-sequencing was
9,417,307. Window sizes of 300 bp for H3K4me3, 500 bp for
H3K27me3, 500 bp for DNA methylation and 300 bp for Smad1,
were used to calculate the number of mapped reads per million
reads at the center of the window. Sequencing data is also
available (#GSE18125).
Immunoblot analysis
Aliquots of protein were subjected to SDS/PAGE and were
transferred to nitrocellulose, and the resulting immunoblots were
visualized using Amersham ECL Plus (GE Healthcare) and LAS-
3000 (Fujifilm, Japan).
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Phosphorylated Smad1/5/8 was detected using antibody
against phospho-Smad1/5/8 (Cell Signaling) as primary antibody,
and green-fluorescent Alexa Fluor 488 dye-labeled anti-rabbit
antibody (Invitrogen) as secondary antibody. RasV12 with N-
terminal FLAG tag and Smad6 with N-terminal Myc tag were
detected using antibody against FLAG (F7425, Sigma, rabbit
polyclonal) and Myc (9E10, Santa Cruz, mouse monoclonal) as
primary antibody, respectively, and Alexa Fluor 594 anti-rabbit
antibody and Alexa Fluor 488 anti-mouse antibody (Invitrogen) as
secondary antibody. Photographs were taken with Biozero BZ-
8100 (KEYENCE, Osaka, Japan).
Senescence-associated b-galactosidase (SA-bgal) analysis
MEFp2 and infected MEFs on day 10, and infected IMR90 on
day 7 underwent SA-bgal staining as previously described [64].
Growth curve
Infected MEFs were counted on days 3, 7, 10, 14, 17, 21 using
Countess automated cell counter (Invitrogen) and seeded at
density of 1610
5 cells/6-cm dish for every passage. Infected
IMR90 were counted on days 4, 8, 12 and 16 similarly, and seeded
at density of 2.5610
5 cells/6-cm dish. Mean number of three
dishes was calculated and used to draw growth curve.
Quantitative real-time RT-PCR, ChIP-PCR, and MeDIP-PCR
Real-time PCR was performed using iCycler Thermal Cycler
(Bio-Rad Laboratories) as previously described [65]. The exper-
iment was triplicated and mean and standard error were
calculated and shown. Primer information is in Tables S7 and S8.
Bisulfite treatment and bisulfite sequencing
DNA methylation status was analyzed by bisulfite sequencing as
previously described [65]. Briefly, 500 ng of genomic DNA of
MEFp2 and RasV12 cells underwent bisulfite treatment, and were
finally suspended in 20 mL of distilled water. For bisulfite
sequencing, 1 ml was used as a template for PCR with primers
common for methylated and unmethylated DNA sequences. The
primers and PCR conditions are available at Table S9. PCR
products were cloned into pGEM-T Easy vector (Promega), and
9–10 clones each were cycle-sequenced using T7 and Sp6 primers.
Supporting Information
Figure S1 Schema of experiments. (A) Candidate factors to
induce senescence are to be identified from genes upregulated,
with loss of repressive epigenetic mark and with gain of active
mark. (B) Candidate inhibitors to senescence are to be identified
from genes downregulated, with gain of repressive epigenetic mark
and with loss of active mark.
(TIF)
Figure S2 Induction of activated Ras by retrovirus infection. (A)
Western blot analysis of Ras protein. Expression of Ras protein with
N-terminal FLAG tag was confirmed by western blot analysis using
anti-FLAG antibody. (B) Count of senescence-associated b-
galactosidase (SA-bgal)-positive cells. MEF cells at passage 2
(MEFp2, open box) rarely showed SA-bgal(+) cells. MEF cells at
passage 5 without virus infection (MEFp5, open box) showed slight
increase innumber ofSA-bgal(+) cells,andtwocontrol cellsinfected
with mock vector (Mock cells, horizontal-striped box) and wild type Ras
(RasG12 cells, crosshatched box) showed similar level of SA-bgal
staining, indicating stress-induced senescence during passages. The
stress response is a consequence of the high oxygen levels that inflict
oxidative damage to the cells resulting in senescence [16]. RasV12-
infected cells (RasV12 cells, closed box) showed marked increase in
number of SA-bgal(+) cells. Representatives were mean and
standard error in three repeated experiments.
(TIF)
Figure S3 Distribution of epigenetic marks. (A) Distribution of
H3K4me3 and H3K27me3 marks around TSS was shown by the
number of mapped Solexa reads per million reads within a
window size of 300 bp and 500 bp, respectively. The distribution
was similar between MEFp2 and RasV12. The peak of H3K4me3
mark was detected at +247 bp for MEFp2, and at +312 bp for
RasV12, and distribution was rather narrow. The peak of
H3K27me3 mark was detected at +698 bp for MEFp2, and at
+420 bp for RasV12, and distribution was rather wide than
H3K4me3. (B) Epigenetic statuses of H3K4me3 and H3K27me3
for each gene were decided by the maximum number of mapped
reads per million reads in a window size of 300 bp and 500 bp,
respectively, within 2 kb 6 TSS of each gene, and distribution of
the epigenetic status of 20,232 genes was shown by heat map. The
number of H3K27me3(+) genes was generally decreased.
(TIF)
Figure S4 Expression analysis of Ezh2 and Jmjd3. Real-time RT-
PCR was performed, and normalized to Ppib, and relative
expression levels compared to MEFp2 was shown. Ezh2 expression
level was decreased in RasV12-induced senescence, but similar
downregulation was observed during three passages without viral
infection, or with mock and RasG12 infection. Similarly, Jmjd3
expression level was increased in RasV12-induced senescence, but
similar upregulation was observed during three passages without
viral infection, or with mock and RasG12 infection.
(TIF)
Figure S5 Relation between expression and histone marks (+/2).
(A) For epigenetic status of H3K4me3, genes with .4 reads per
million reads within a window size of 300 bp were regarded as
H3K4me3(+), and genes with ,3 reads were as H3K4me3(-). Mean
and standard error of expression signal (GeneChip score) were shown.
Markedly high expression was confirmed in H3K4me3(+) genes. (B)
For epigenetic status of H3K27me3, genes with .1.5 reads per
million reads within a window size of 500 bp were regarded as
H3K27me3(+), and genes with ,1 read were as H2K27me3(-).
Markedly low expression was confirmed in H3K27me3(+) genes.
(TIF)
Figure S6 Decreased enrichment of Ezh2 around TSS of Bmp2.
Quantitative ChIP-PCR was performed for ,100 bp upstream
(region 1) and ,300 bp downstream (region 2)o fBmp2 TSS (See
Figure 3A), and shown by relative fold enrichment compared to
Actb (Figure 1D). Decreased enrichment of Ezh2 around Bmp2
TSS was shown (*P,0.05).
(TIF)
Figure S7 Cellular immunofuorescence for RasV12 and Smad6.
RasV12 with N-terminal FLAG and Smad6 with N-terminal Myc
were detected using anti-FLAG and anti-Myc antibodies. Simulta-
neous expression of RasV12 and Smad6 proteins in Smad6-
introduced RasV12 cells was confirmed (See also Figure 4E).
(TIF)
Figure S8 Decreased SA-bgal(+) cells by Smad6 overexpression.
Retrovirus of Smad6 cDNA was infected with Mock or RasV12
retrovirus. Smad6-induced RasV12 cells showed decreased number
of SA-bgal(+) cells compared to RasV12 cells (black box). Smad6
induction did not affect on Mock cells (horizontally striped box).
(TIF)
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that MEFp2 showed expression of Krt19 in MEFp2 and not in
brain and testis. (B) Real-time RT-PCR showed that Krt19
expression level in MEFp2 was much higher than brain and testis.
(TIF)
Figure S10 Ras-induced senescence in human fibroblast IMR90.
(A) IMR90 was infected with RasV12 retrovirus. In western
blotting, expression of Ras protein with N-terminal FLAG tag on
day 4 was detected using anti-FLAG antibody (left). SA-bgal
staining on day 7 showed that RasV12-IMR90 cells fell into
senescence (right). (B) Real-time RT-PCR showed that BMP2
expression was markedly increased to 145-fold in RasV12-IMR90
cells, while SMAD6 and NOG expressions were decreased to 0.32-
fold and 0.15-fold, respectively. (C) Nog-induced RasV12-IMR90
cells showed continual cellular growth.
(TIF)
Figure S11 ChIP using anti-Smad1 antibody. (A) There was no
Smad1 binding site detected around Actb, while a Smad1 binding
site was detected at 1 kb upstream of Id1 TSS. open squares, regions
for ChIP-PCR. (B) Smad1 binding at 1 kb upstream of Id1 TSS
was validated by ChIP-PCR.
(TIF)
Figure S12 The motifs within Smad1 binding regions by
GADEM. GADEM version1.3 (http://www.niehs.nih.gov/research/
resources/software/gadem/index.cfm) was used to search for the
motifs with default parameters except -posWt (Weight profile for
positions on the sequence) =1, -pv (P-value cutoff) =0.00001, -em
(Number of EM steps) =20, and -fullScan =1. The enriched
sequences were drawn by STAMP (http://www.benoslab.pitt.edu/
stamp/). Ln(E-value) and fold-enrichment to sites in background
sequence were shown. 20 and 10 motifs were obtained in whole
genomic region (All) and TSS regions (TSS), respectively. GGG-
GCGGGGC was commonly detected in both analyses.
(TIF)
Figure S13 The motifs within Smad1 binding regions by DME.
To confirm the GADEM result (Figure S9), the motifs were
searched for by another software DME2 (http://rulai.cshl.edu/
dme/), using ZOOPS model with default parameters except -w
(minimum desired motif width) =10 and -n (number of motifs to
produce) =10. The results were drawn by STAMP, including the
tree view at the bottom. It was confirmed that DNA sequences
very similar to GGGGCGGGGC were enriched, such as
GGGGCGGGGM and GGGCGGGGC.
(TIF)
Figure S14 Parvb in Ras-induced senescence. (A) Real-time RT-
PCR showed that Parvb was knocked down by shRNA to 0.05-fold.
(B) Parvb-knocked down RasV12 cells showed partially decreased
number of SA-bgal(+) cells compared to RasV12 cells, though
higher than Mock level.
(TIF)
Table S1 Significant terms with P,10
210 were listed. When
there were less than five terms with P,10
210, top five terms with
P,10
25 were listed for each category. * The term included Bmp2.
(DOC)
Table S2 Significant terms with P,10
210 were listed. When
there were less than five terms with P,10
210, top five terms with
P,10
25 were listed for each category.
1 The term included Smad6.
(DOC)
Table S3 H3K4me3 and H3K27me3 levels were shown by the
maximum number of the mapped Solexa reads per million reads
within a window size of 300 bp and 500 bp, respectively, for 2 kb
around TSS. Expression levels were shown by GeneChip score.
Secreted factors Bmp2 and Igfbp3 were shown to be highly
upregulated with H3K27me3 loss and H3K4me3 gain.
(DOC)
Table S4 H3K4me3 and H3K27me3 levels were shown by the
maximum number of the mapped Solexa reads per million reads
within a window size of 300 bp and 500 bp, respectively, for 2 kb
around TSS. Expression levels were shown by GeneChip score.
Two Bmp2/Smad1 signal inhibitors, Smad6 and Nog, were
included in the nine genes with H3K27me3 gain and H3K4me3
loss.
(DOC)
Table S5 Smad1 target genes were generally upregulated by
Bmp2 stimulation in MEF (Figure 6), but genes with H3K27me3
increase e.g. Smad6 and Atoh8 were repressed in RasV12 cells.
Smad1 target genes without H3K27me3 increase were correlated
to upregulation (Figure 7 and Table S6).
(DOC)
Table S6 Smad1 target genes without H3K27me3 increase were
correlated to upregulation (Figure 7). Among Smad1 target genes
upregulated in RasV12 cells, top ranking 30 genes showing .3-
fold upregulation were listed. None of these genes showed
H3K27me3 increase .0.4. These genes were regarded as
selectively upregulated Smad1 target genes, and expected to
include genes with growth suppressor function. Such genes may
perhaps be frequently inactivated in human cancer e.g. by
promoter methylation. Among these genes, Parvb was chosen to
be examined as Parvb expression was highly induced by BMP2
stimulation in MEF (Figure 6) and our previous methylated DNA
immunopreccipitation (MeDIP)-chip analysis of human cancer cell
lines [22,23] showed PARVB promoter methylation in HCT116
and DLD1 (the most right columns above).
(DOC)
Table S7 Ppib and PPIA were used for normalization.
(DOC)
Table S8 Location of TSS was regarded as +1.
(DOC)
Table S9 Location of TSS was regarded as +1.
(DOC)
Text S1 Supporting Materials and Methods.
(DOC)
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